Back

Fibroblast growth factor-23 (FGF23), an early biomarker of sublinical kidney dysfunction, is associated with poor prognosis in acute coronary syndrome patients

25 August 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 2 - Biomarkers in acute coronary syndromes Biomarkers ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Troels Yndigegn

Department of Cardiology, Lund (Sweden)

9 More presentations in this session

Presentation thumbnail
Physical exercise induces coronary artery collateral growth and affects cardiovascular biomarkers: A biomarker sub-analysis of the EXCITE trial
Professor M. Lichtenauer (Salzburg, AT)
Abstract
Presentation thumbnail
Direct comparison of the 0/1h- and 0/3h-algorithm for early rule-out of acute myocardial infarction
Associate Professor P. Badertscher (Basel, CH)
Abstract
Presentation thumbnail
The association of biological markers of inflammation with the severity of cardiofibrosis in patients with ST-segment elevation myocardial infarction
Professor O. Barbarash (Krasnodar, RU)
Abstract
Presentation thumbnail
Validation of limb leads in localizing culprit artery in inferior STEMI
Doctor A. Smith (Biloxi, US)
Abstract Slides
Presentation thumbnail
Panel of emerging cardiac biomarkers in patients with acute chest pain
Mr J. Hupf (Regensburg, DE)
Abstract

Access the full session

Session thumbnail
Poster Session 2 - Biomarkers in acute coronary syndromes

The Event

Event poster

ESC Congress 2018

25 August - 29 August 2018

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources